Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
10 pending office actions • 5 art units • 8 examiners • 0 of 10 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days
Exact Sciences Corporation has 10 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 8 distinct examiners and 5 distinct art units, indicating a broad prosecution footprint with multiple examination practices in play.
SALMON, KATHERINE D is the busiest examiner, with 2 pending matters. That examiner provides a useful point for identifying possible recurring issues, but the distribution across the other examiners means counsel should avoid assuming that one response approach will fit the entire portfolio.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (20%) |
| §103 only | 3 (30%) |
| §112 only | 1 (10%) |
| Double-patenting + other | 2 (20%) |
| Multi-statute (no §101) | 1 (10%) |
| No statute on record | 1 (10%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SALMON, KATHERINE D | 2 | 42.9% | +37.7% |
| GOLDBERG, JEANINE ANNE | 2 | 45.4% | +40.5% |
| BROWN, MINDY G | 1 | 57.8% | +40.5% |
| NGUYEN, HUONG Q | 1 | 46.2% | +44.4% |
| XU, XIAOYUN | 1 | 59.9% | +31.6% |
| SIEFKE, SAMUEL P | 1 | 63.0% | +17.8% |
| HANEY, AMANDA MARIE | 1 | 36.5% | +45.0% |
| KENNEDY, SARAH JANE | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18643723 | Method for Stabilizing Hemoglobin and Reagents for Performing the Same | XU, XIAOYUN | — |
| 17921711 | DETECTING MELANOMA | KENNEDY, SARAH JANE | — |
| 17741305 | METHYLATED CONTROL DNA | GOLDBERG, JEANINE ANNE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17727128 | DETECTING ESOPHAGEAL DISORDERS | GOLDBERG, JEANINE ANNE | 104d overdue |
| 18943512 | FECAL SAMPLE PROCESSING AND ANALYSIS COMPRISING DETECTION OF BLOOD | BROWN, MINDY G | 45d overdue |
| 18353647 | COMPOSITIONS AND METHODS FOR CHARACTERIZING ZDHHC1 DNA | HANEY, AMANDA MARIE | 33d |
| 18655072 | SAMPLE COLLECTION DEVICE | NGUYEN, HUONG Q | — |
| 18643723 | Method for Stabilizing Hemoglobin and Reagents for Performing the Same | XU, XIAOYUN | — |
| 18480959 | ENCLOSING HOLDER FOR PROCESSING A SAMPLE IN A CONTAINER | SIEFKE, SAMUEL P | — |
| 18323031 | DETECTING PROSTATE CANCER | SALMON, KATHERINE D | — |
| 17741305 | METHYLATED CONTROL DNA | GOLDBERG, JEANINE ANNE | — |
| Art Unit | Apps |
|---|---|
| 1682 | 6 |
| 1683 | 1 |
| 3791 | 1 |
| 1797 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18943512 | FECAL SAMPLE PROCESSING AND ANALYSIS COMPRISING DETECTION OF BLOOD | BROWN, MINDY G | 1683 | §112 | Non-Final OA | 45d overdue | Pending | Nov 11, 2024 |
| 18655072 | SAMPLE COLLECTION DEVICE | NGUYEN, HUONG Q | 3791 | §103 | Final Rejection | — | Pending | May 03, 2024 |
| 18643723 | Method for Stabilizing Hemoglobin and Reagents for Performing the Same | XU, XIAOYUN | 1797 | §102§103 | Non-Final OA | — | Pending | Apr 23, 2024 |
| 18480959 | ENCLOSING HOLDER FOR PROCESSING A SAMPLE IN A CONTAINER | SIEFKE, SAMUEL P | 1758 | §102§103DP | Non-Final OA | — | Pending | Oct 04, 2023 |
| 18353647 | COMPOSITIONS AND METHODS FOR CHARACTERIZING ZDHHC1 DNA | HANEY, AMANDA MARIE | 1682 | Other | Non-Final OA | 33d | Pending | Jul 17, 2023 |
| 18323031 | DETECTING PROSTATE CANCER | SALMON, KATHERINE D | 1682 | §103 | Non-Final OA | — | Pending | May 24, 2023 |
| 17921711 | DETECTING MELANOMA | KENNEDY, SARAH JANE | 1682 | §101§103 | Non-Final OA | — | Pending | Oct 27, 2022 |
| 17741305 | METHYLATED CONTROL DNA | GOLDBERG, JEANINE ANNE | 1682 | §101DP | Non-Final OA | — | Pending | May 10, 2022 |
| 17727128 | DETECTING ESOPHAGEAL DISORDERS | GOLDBERG, JEANINE ANNE | 1682 | §103DP | Non-Final OA | 104d overdue | Pending | Apr 22, 2022 |
| 17587963 | DETECTING THE PRESENCE OR ABSENCE OF MULTIPLE TYPES OF CANCER | SALMON, KATHERINE D | 1682 | §103 | Non-Final OA | — | Pending | Jan 28, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialExact Sciences Corporation has 10 pending office actions as of October 2026, spread across 5 art units and 8 examiners.
Katherine D Salmon has the most, with 2 of Exact Sciences Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
